Sepsis & infection

Severe dengue in adults admitted to intensive care units on réunion island: clinical spectrum, outcomes, and predictors of mortality

Crit CarePublished Retrospective cohort study

Authors' conclusion

SD on Réunion Island exhibited a wide clinical spectrum in ICUs and was associated with substantial mortality, primarily due to multiple organ failure rather than hemorrhagic complications. Co-infections were common, and comorbidities likely contributed to unfavorable outcomes.

Study context

Population
Adults admitted to the five intensive care units (ICUs) of Réunion Island, January 2017–December 2022, with laboratory-confirmed severe dengue (US CDC criteria)
Participants
137 severe dengue ICU admissions
Outcome
In-hospital mortality
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

In-hospital mortality rate

25%

Catecholamine use, independent predictor of mortality (OR [CI], P)

OR 4.71

1.58–14.07p = 0.005

Respiratory rate at admission, independent predictor of mortality (OR [CI], P)

OR 1.10

1.03–1.17p = 0.004

Observational data: associations, not effects.

Further findings

ICU admission rate among confirmed dengue cases

Confirmed dengue cases
72.434
Required hospitalization
2.817
ICU admissions per 1,000 infections
1.8

Clinical spectrum

Median age, years (IQR 50-70)
63
Male
62%
Circulatory failure
62%
Distributive shock
12%
Myocarditis
9%
Veno-arterial extra corporeal membrane oxygenation (VA-ECMO) required (patients)
6
Hepatic failure
50%
Renal failure
59%
Neurological presentations, 13 patients
9%
Co-infection
33%
Initial diagnosis other than dengue, 52 patients
38%
Thrombocytopenia
78%
Hemorrhagic events uncommon

Original publication

Severe dengue in adults admitted to intensive care units on réunion island: clinical spectrum, outcomes, and predictors of mortality. Crit Care. Published 27 November 2025. doi:10.1186/s13054-025-05779-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.